Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction

Addictive Behaviors - Tập 79 - Trang 159-165 - 2018
Khary K. Rigg1, Amanda Sharp2
1Department of Mental Health Law & Policy, Louis de la Parte Florida Mental Health Institute, College of Behavioral & Community Sciences, University of South Florida, United States
2Department of Mental Health Law & Policy, College of Behavioral & Community Sciences, University of South Florida, United States

Tài liệu tham khảo

Almeida de, 2005, Characteristics of ecstasy users in São Paulo, Brazil, Substance Use & Misuse, 40, 395, 10.1081/JA-200052290 Badon, 2002, Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy, Journal of Pharmacology and Experimental Therapeutics, 302, 898, 10.1124/jpet.302.3.898 Becker, 2007, Non-medical use, abuse and dependence on sedatives and tranquilizers among US adults: psychiatric and socio-demographic correlates, Drug and Alcohol Dependence, 90, 280, 10.1016/j.drugalcdep.2007.04.009 Bellum, S. (2013, April). Rap music and molly. Retrieved from: https://teens.drugabuse.gov/blog/post/rap-music-and-molly. Boeri, 2008, Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns, Journal of Drug Issues, 38, 517, 10.1177/002204260803800207 Boeri, 2004, Rolling beyond raves: Ecstasy use outside the rave setting, Journal of Drug Issues, 34, 831, 10.1177/002204260403400406 Boyd, 2014, Race/ethnicity and gender differences in drug use and abuse among college students, 6(2), 75 Boyd, 2006, Adolescents' motivations to abuse prescription medications, Pediatrics, 118, 2472, 10.1542/peds.2006-1644 Buttram, 2013, Substance use and sexual risk mediated by social support among black men, Journal of Community Health, 38, 62, 10.1007/s10900-012-9582-8 Center for Behavioral Health Statistics and Quality, 2015 Charmaz, 2000, Grounded theory: Objectivist and constructivist methods, 509 Charmaz, 2003, Qualitative interviewing and grounded theory analysis, 311 Chodosh Chromy, 2010 Cohen, 1996, Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; ‘ecstasy’), Biological Psychiatry, 39, 816, 10.1016/0006-3223(95)00551-X Community Epidemiology Work Group Copeland, 2006, Ecstasy and the concomitant use of pharmaceuticals, Addictive Behaviors, 31, 367, 10.1016/j.addbeh.2005.05.025 Curran, 1997, Mood and cognitive effects of ±3, 4- methylenedioxymethamphetamine (MDMA,‘ecstasy’): Week-end ‘high’ followed by mid-week low, Addiction, 92, 821 Dart, 2015, Trends in opioid analgesic abuse and mortality in the United States, New England Journal of Medicine, 372, 241, 10.1056/NEJMsa1406143 Diamond, 2006, What’s the Rap About Ecstasy? Popular Music Lyrics and Drug Trends Among American Youth, Journal of Adolescent Research, 21, 269, 10.1177/0743558406287398 Dowling, 1987, ‘Eve'and'ecstasy’: A report of five deaths associated with the use of MDEA and MDMA, JAMA, 257, 1615, 10.1001/jama.1987.03390120077027 Dowling, 2006, Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population, The Clinical Journal of Pain, 22, 776, 10.1097/01.ajp.0000210926.41406.2c Freudenmann, 2006, The origin of MDMA (ecstasy) revisited: The true story reconstructed from the original documents, Addiction, 101, 1241, 10.1111/j.1360-0443.2006.01511.x Ford, 2015, Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse, Prevention Science, 16, 633, 10.1007/s11121-014-0514-y Gerevich, 2000, Combination of heroin and ecstasy with fatal outcome, Psychiatria Hungarica, 15, 583 Gilhooly, 2002, CYP2D6 deficiency, a factor in ecstasy related deaths?, British Journal of Clinical Pharmacology, 54, 69, 10.1046/j.1365-2125.2002.01574.x Gill, 2002, Ecstasy (MDMA) deaths in New York City: A case series and review of the literature, Journal of Forensic Science, 47, 121, 10.1520/JFS15211J Giorgi, 2006, MDMA and seizures: A dangerous liaison?, Annals of the New York Academy of Sciences, 1074, 357, 10.1196/annals.1369.035 Harrell, 2009, Racial/ethnic differences in correlates of prescription drug misuse among young adults, Drug and Alcohol Dependence, 104, 268, 10.1016/j.drugalcdep.2009.05.017 Herman-Stahl, 2006, Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents, Journal of Adolescent Health, 39, 374, 10.1016/j.jadohealth.2006.01.006 Iritani, 2007, Crystal methamphetamine use among young adults in the USA, Addiction, 102, 1102, 10.1111/j.1360-0443.2007.01847.x Johnston, 2006, Software and method: Reflections on teaching and using QSR NVivo in doctoral research, International Journal of Social Research Methodology, 9, 379, 10.1080/13645570600659433 Johnston, 2014 Kalant, 2001, The pharmacology and toxicology of “ecstasy”(MDMA) and related drugs, Canadian Medical Association Journal, 165, 917 Kandel, 2017, Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances, Drug & Alcohol Dependence, 178, 501, 10.1016/j.drugalcdep.2017.05.047 Klitzman, 2002, MDMA (‘ecstasy’) use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City, Drug and Alcohol Dependence, 66, 115, 10.1016/S0376-8716(01)00189-2 Klitzman, 2000, MDMA (“Ecstasy”) abuse and high-risk sexual behaviors among 169 gay and bisexual men, American Journal of Psychiatry, 157, 1162, 10.1176/appi.ajp.157.7.1162 Klosinski, 2017, Potential psychiatric uses for MDMA, Clinical Pharmacology & Therapeutics, 101, 194, 10.1002/cpt.565 Kroutil, 2006, Nonmedical use of prescription stimulants in the United States, Drug and Alcohol Dependence, 84, 135, 10.1016/j.drugalcdep.2005.12.011 Kurtz, 2017, Benzodiazepine dependence among young adult participants in the club scene who use drugs, Journal of Psychoactive Drugs, 49, 39, 10.1080/02791072.2016.1269978 Kurtz, 2006, Prescription drug abuse among ecstasy users in Miami, Journal of Addictive Diseases, 24, 1, 10.1300/J069v24n04_01 Lamers, 2003, Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance, Journal of Psychopharmacology, 17, 379, 10.1177/0269881103174015 Lofland, 1995 McCabe, 2005, Correlates of nonmedical use of prescription benzodiazepine anxiolytics: Results from a national survey of US college students, Drug and Alcohol Dependence, 79, 53, 10.1016/j.drugalcdep.2004.12.006 McCabe, 2008, Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys, Addictive Behaviors, 33, 1297, 10.1016/j.addbeh.2008.06.005 Mohamed, 2011, MDMA: interactions with other psychoactive drugs, Pharmacology Biochemistry and Behavior, 99, 759, 10.1016/j.pbb.2011.06.032 Montoya, 2002, Long-term neuropsychiatric consequences of" ecstasy"(MDMA): A review, Harvard Review of Psychiatry, 10, 212, 10.1080/10673220216223 Narvaez, 2001, MDMA in combination: “Trail mix” and other powdered drug combinations National Institute on Drug Abuse [NIDA], 2006 Oesterheld, 2004, Ecstasy: Pharmacodynamic and pharmacokinetic interactions, Psychosomatics, 45, 84, 10.1176/appi.psy.45.1.84 Ouellet, 2014, Patterns and trends of drug abuse in Chicago, 2013 Palamar, 2014, An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States, Substance Use & Misuse, 49, 1774, 10.3109/10826084.2014.926933 Palamar, 2017, Shifting characteristics of ecstasy users ages 12–34 in the United States, 2007–2014, Drug & Alcohol Dependence, 181, 20, 10.1016/j.drugalcdep.2017.09.011 Parrott, 2012, MDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humans, Drug and Alcohol Dependence, 121, 1, 10.1016/j.drugalcdep.2011.08.012 Pilgrim, 2011, Deaths involving MDMA and the concomitant use of pharmaceutical drugs, Journal of Analytical Toxicology, 35, 219, 10.1093/anatox/35.4.219 Rigg, 2017, Motivations for using MDMA (ecstasy/molly) among African Americans: Implications for prevention and harm-reduction programs, Journal of Psychoactive Drugs, 49, 192, 10.1080/02791072.2017.1305518 Rigg, 2017, MDMA (ecstasy/molly) use among African Americans: Patterns of initiation, International Journal of Mental Health and Addiction, 1 Rigg, 2017, Perceived risk associated with MDMA (ecstasy/molly) use among African Americans: What prevention and treatment providers should know, Substance Use & Misuse, 1 Schifano, 2004, A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities, Psychopharmacology, 173, 242, 10.1007/s00213-003-1730-5 Schifano, 2005, Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003), Journal of Psychopharmacology, 20, 456, 10.1177/0269881106060147 Schifano, 2003, Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002, Human Psychopharmacology: Clinical and Experimental, 18, 519, 10.1002/hup.528 Silins, 2009, Patterns and harms of pharmaceutical drug use among ecstasy users in Australia, Adicciones, 21 Simoni-Wastila, 2004, Risk factors associated with problem use of prescription drugs, American Journal of Public Health, 94, 266, 10.2105/AJPH.94.2.266 Singer, 2004, Psychosocial profiles of older adolescent MDMA users, Drug and Alcohol Dependence, 74, 245, 10.1016/j.drugalcdep.2003.12.015 Smith, 2009, MDMA powder, pills and crystal: The persistence of ecstasy and the poverty of policy, Drugs and Alcohol Today, 9, 13, 10.1108/17459265200900004 Snow, 2013 Soar, 2001, Psychiatric disorders in Ecstasy (MDMA) users: A literature review focusing on personal predisposition and drug history, Human Psychopharmacology: Clinical and Experimental, 16, 641, 10.1002/hup.350 Steinhardt, 2014, Have you seen Molly? A review of molly in primary literature, Mental Health Clinician, 4, 231, 10.9740/mhc.n207181 Strote, 2002, Increasing MDMA use among college students: Results of a national survey, Journal of Adolescent Health, 30, 64, 10.1016/S1054-139X(01)00315-9 Substance Abuse and Mental Health Services Administration [SAMHSA], 2005 Substance Abuse and Mental Health Services Administration [SAMHSA], 2015 Substance Abuse and Mental Health Services Administration [SAMHSA], 2013, Ecstasy-related emergency department visits by young people increased between 2005 and 2011 Vaiva, 2001, An “accidental” acute psychosis with ecstasy use, Journal of Psychoactive Drugs, 33, 95, 10.1080/02791072.2001.10400473 Vuori, 2003, Death following ingestion of MDMA (ecstasy) and moclobemide, Addiction, 98, 365, 10.1046/j.1360-0443.2003.00292.x Yacoubian, 2003, It's a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees, Journal of Drug Education, 33, 187, 10.2190/RJX5-WRA6-BNG5-Q2TY